BioSpace News Archive

SpeciCare Offers Patients Cancer Treatment Breakthrough For Newly Diagnosed and Re-Diagnosed Cancer Patients

Compugen Ltd. (Nasdaq: CGEN), a clinical-stage cancer immunotherapy company and leader in predictive target discovery, announced today that The European Patent Office (EPO) has granted the Company a new patent for the composition of COM701 or backup antibodies for the treatment of cancer. EPO Patent No. 3295951 , titled “Anti-P

Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage biopharmaceutical company focused on the development and commercialization of precisely targeted oncology therapies and the utilization of novel biomarkers to enhance patient selection, today announced that the Company will host a conference call and webcast on April 30, 2020 at 4:30 pm ET (1:30 pm PT) to provide a business update and report first quarter 2020 financial results.

Vericel Corporation announced the following webcast and conference call to discuss its first-quarter 2020 financial results and business highlights.

New Laboratory Tests Conducted by Utah-Based Institute for Antiviral Research Confirm SaNOtize’s Nitric Oxide Releasing Solution (NORS TM ) is Over 99.9% Effective Against SARS-CoV-2, the Virus that Causes COVID-19 VANCOUVER , April 22, 2020 /CNW/ - SaNOtize Research and Development Corporation (“SaNOtize” or “the company”) today announced that it has be

Artificial Intelligence (AI) and computational biophysics will be deployed to rapidly develop drugs for COVID-19 and other viral infections based on Mannin Research’s Tie2 platform in new joint venture with Cyclica

Yiling Pharmaceutical announced that Lianhua Qingwen capsules have been added to the “Novel Coronavirus Pneumonia Diagnosis and Treatment Scheme for Laos” as the fourth traditional Chinese medicine to treat COVID-19 pneumonia in Laos.

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) provided today details of its plans to report first quarter 2020 financial results on May 6, 2020. Ligand’s CEO John Higgins, President and COO Matt Foehr and Executive Vice President and CFO Matt Korenberg will host the conference call. What: Ligand conference call to discuss financial results and provide general business updates

Invacare Corporation (NYSE:IVC) (“Invacare” or the “company”) announces that it will release its financial results for the first quarter ended March 31, 2020, after the market closes on Wednesday, May 6, 2020. The company will provide a live conference call and webcast to discuss these financial results on Thursday, May 7, 2020 at 8:30 AM ET. Investors and other interested par

Nascent Biotech, Inc., a leading biotechnology company developing proprietary human Monoclonal Antibodies and immunotherapy for treatment of cancer, is pleased to present its corporate update and a dynamic strategic plan, which the company has begun executing in 2020.